Awareness and use of the Rapid Palliative Radiotherapy Program by family physicians in Eastern Ontario: a survey by Fitzgibbon, E.J. et al.
AWARENESS AND USE OF THE RPRP
27
CURRENT ONCOLOGY—VOLUME 13, NUMBER 1
ABSTRACT
The Ottawa Rapid Palliative Radiotherapy Program
(RPRP) was established in 1999 with the goal of facili-
tating access by family physicians to radiotherapy
services for patients with advanced symptomatic can-
cer. Two years later, an audit revealed that of the
148 patients treated by the program, only 19 had been
referred by family physicians.
We therefore assessed awareness of the RPRP and
perceptions of the effectiveness of palliative radio-
therapy on the part of family physicians by survey-
ing a random sample of family physicians in Eastern
Ontario.
Response rate was 50%. Only 18% of family
physicians were aware of the RPRP, although 56% had
previously referred patients for palliative radio-
therapy. Among responders, 80% regularly provided
palliative care, and these physicians were much more
likely to be aware of and to refer patients for pallia-
tive radiotherapy.
Our survey confirms the key role that family phy-
sicians play in providing care to patients with ad-
vanced cancer. However, significant deficits in family
physician awareness of palliative radiotherapy pro-
grams and in knowledge of the effectiveness of pal-
liative radiotherapy should be addressed to improve
patient care.
KEY WORDS
Palliative radiotherapy, effectiveness, family physi-
cian, awareness, survey
1. INTRODUCTION
Painful metastatic bone disease is the most common
indication for radiotherapy among patients with ad-
vanced cancer, accounting for more than 20% of all
radiotherapy treatments 1,2. It is estimated that 60%
to 80% of patients with advanced cancer will develop
bone metastases, with 65% of those patients devel-
oping bone pain 3–8. For these patients, local exter-
nal-beam radiotherapy is considered to be an
effective, rapidly acting, palliative intervention 4–6.
A systematic review of palliative radiotherapy trials
reported that, among patients with painful bone me-
tastases, “complete pain relief” was obtained in 21%
to 80% and “partial pain relief” was obtained in 25%
to 87%. The median duration of complete pain relief
was 12 weeks, regardless of the radiation fraction-
ation schedule used 9.
In 1996, a Canadian symposium on palliative
radiotherapy concluded that “a separate palliative
radiotherapy clinic, where access is rapid and patients
can be assessed, planned, and treated the same day,
is an excellent way of handling the special needs of
palliative patients” 10. Following this report, the first
rapid response radiotherapy program was developed
in Toronto, Ontario, to facilitate access to radiotherapy
for cancer patients with an estimated life expectancy
of less than 6 months 11. Subsequent program evalu-
ations have demonstrated a high degree of support
from both patients and referring physicians 12–14.
The Ottawa Rapid Palliative Radiotherapy Pro-
gram (RPRP) was established in 1999 with the spe-
cific goal of providing family physicians with rapid
access to radiotherapy consultation and treatment for
their patients with advanced symptomatic cancer. A
retrospective chart audit revealed that 148 patients
had been treated by the RPRP during the period No-
vember 1999 to December 2001. That total included
60 patients referred by 22 family physicians (of which
41 were referred by 5 physicians who were exclu-
sively practicing palliative care) and 88 patients re-
ferred by 21 oncologists. Painful metastatic bone
disease was the primary reason for referral in 81% of
the patients. The primary objective of this survey was
to assess  awareness of the RPRP and barriers to the
use palliative radiotherapy among family physicians
in eastern Ontario.
2. METHODS
2.1 Survey Design and Sampling Frame
The survey design was developed by a panel com-
posed of a palliative care physician (EF) a survey
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methodologist (IG), and two radiation oncologists
(JM, RS). The survey questionnaire used the Ottawa
Model of Research Use and the Rogers innovation
decision process to gather data on factors influenc-
ing the adoption of a clinical innovation 15,16. The
survey included these sections:
• Respondent characteristics
• Awareness of and perceived accessibility to on-
cology services at the regional cancer centre
• Factors influencing patient referral for palliative
radiotherapy
• Perception of the effectiveness of palliative
radiotherapy
• Willingness to attend continuing medical educa-
tion on radiation oncology
To establish content validity, clarity, and ease of
completion, the questionnaire was piloted with 75
family physicians attending an oncology conference.
The revised version consisted of 50 questions and
required 10–15 minutes to complete.
Family physicians in Eastern Ontario were iden-
tified from two lists:
• The Ottawa Regional Cancer Centre list, which
included family physicians who had referred pa-
tients for cancer treatment from 1991 to 2001
• The list published in the Canadian Medical Di-
rectory from Southam Information Products
After exclusion of physicians with primary ac-
tivity in emergency medicine, internal medicine, sur-
gery, and psychiatry, and of those with outdated
addresses or telephone numbers, we finalized a list
of 997 family physicians. The surveys were admin-
istered using a modification of Dillman’s design for
the conduct of surveys, with a maximum of four at-
tempts made to contact each physician 17. The inves-
tigators jointly signed all letters.
2.2 Sample Size
The survey sample size was 400 subjects. This sample
was adequate to ensure that a 50% answer to any
dichotomous question would be estimated within a
confidence interval of 5%. Sample size was adjusted
to allow for a minimum expected survey response
rate of 50% 18–21.
All surveys received within 12 weeks of the first
mail-out were screened to exclude from further
analysis those that contained a “yes” answer to ei-
ther of the questions “I do not practice family medi-
cine” or “I do not have cancer patients in my
practice.” Response rates were calculated by divid-
ing the number of completed surveys by the total
number of physicians in the sample, minus the sur-
veys excluded as just described 22. Data were ana-
lyzed using both the SPSS version 11 (SPSS Inc.,
Chicago, IL, U.S.A.) and the SAS version 8 (SAS
Institute, Cary, NC, U.S.A.) statistical software pack-
ages. The Ottawa Hospital Research Ethics Board
approved the survey.
Descriptive statistics were used to report answers
to survey questions. Unpaired t-tests or Pearson chi-
square tests were used as appropriate to compare re-
sponders with non-responders. Because the survey
analysis was descriptive, no adjustment was made
for multiple comparisons, however a conservative
level of significance (a) of p < 0.01 was used to de-
termine the associations that would be reported.
Further statistical analysis included:
• Comparison of the characteristics of family phy-
sicians who completed the survey to those who
did not
• Tabulation of practice characteristics and aware-
ness and perceptions of palliative radiotherapy
• Use of separate logistic regression models to iden-
tify factors independently associated with “aware-
ness” of the RPRP and with previous patient referral
for palliative radiotherapy
A stepwise modelling format was used to con-
struct multivariate logistic regression models that
included variables that met the predetermined selec-
tion criteria of a Wald statistic p(z) < 0.25 in univariate
comparisons. No interaction terms were considered
in the model-building process.
3. RESULTS
Of the 400 randomly selected family physicians, 55
(14%) were excluded for not meeting the survey eli-
gibility criteria. Of the remaining 345 family physi-
cians, 172 (50%) completed the survey, 99 after the
first contact, and 73 after a subsequent contact. Phy-
sicians who completed the survey differed signifi-
cantly from those who did not with respect to family
practice certification status, practice setting, and hos-
pital admitting privileges (Table I).
As shown in Table II, only 31 responders (18%)
were aware of the existence of the RPRP, and only 15
(9%) had referred patients to the RPRP. However 96
responders (56%) had previously referred patients for
palliative radiotherapy outside of the RPRP. In addi-
tion, 149 of the 172 responders (87%) indicated that
they were regularly involved in caring for patients
with advanced cancer and 138 (80%) indicated that
they regularly provided palliative care to their pa-
tients. Of survey responders, 40% had received for-
mal training in palliative care (median: 2 weeks;
range: 1–104 weeks). Only 10% had received any
teaching in radiation oncology. The responding phy-
sicians showed strong support for additional training
in both palliative care (81%) and radiation oncology
(86%). Small-group workshops were the preferred
education format (data not shown).AWARENESS AND USE OF THE RPRP
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Factors that were significantly associated (p <
0.01) with referral of patients for palliative radio-
therapy included type of cancer (80%), patient pref-
erence (79%), and functional status of the patient
(67%). Patient referral was hindered by factors such
as long waiting times for radiotherapy (55%) and
uncertainty of the benefit of radiotherapy (55%)
(Table III). More than 80% of survey responders rated
radiotherapy to be an effective intervention in the
relief of painful metastatic bone disease, brain me-
tastases, painful local disease, and malignant airway
obstruction. However, more than 30% indicated that
they did not know if radiotherapy was an effective
treatment for other established indications, includ-
ing malignant spinal cord compression, tumour-
associated hematuria, and hemoptysis (Figure 1).
Survey responders who had previously referred
patients for palliative radiotherapy differed signifi-
cantly (p < 0.01) from their counterparts who had not
made such referrals. These physicians were more
often male (73% vs. 27%), more likely to be provid-
ing palliative care to their patients (96% vs. 75%),
more likely to be practicing outside of urban centres
(45% vs. 25%), and more likely to have hospital ad-
mitting privileges (62% vs. 40%). They were also
more likely to have previously sought advice from a
radiation oncologist (73% vs. 29%) and to consider
their access to radiation oncologists to be adequate
(60% vs. 35%; Table IV).
Multivariate logistic regression revealed that two
factors were significantly and independently related
to a responder’s “awareness” of the RPRP:
• The physician had previously sought advice from
a radiation oncologist [odds ratio (OR) = 3.13,
95% confidence interval (CI) = 1.15 to 8.53].
• The physician had provided palliative care to pa-
tients (OR = 3.42, 95% CI = 1.32 to 8.86) (Table V).
The same two factors were even more strongly pre-
dictive of the probability of referring a patient for pal-
liative radiotherapy: OR = 5.99 (95% CI: 2.89 to 12.42)
and OR = 5.58 (95% CI: 1.97 to 15.78) respectively.
4. DISCUSSION
Among family physicians who responded to our sur-
vey, 87% regularly cared for patients with advanced
cancer, and 80% provided palliative care. However,
only 18% of responders were aware of the existence
of the RPRP and just 9% had ever referred patients
to the RPRP. Despite this, 56% of responders had pre-
viously referred patients for palliative radiotherapy
outside of the RPRP. Lack of awareness of the RPRP is
a major factor contributing to the low utilization of
the program by family physicians.
The survey revealed that, although only 10% of
responders had received formal teaching in radiation
oncology, 85% were aware of the effectiveness of
TABLE I Differences in characteristics of physicians according to
survey completion
Variable Survey p Value a
completed? [n (%)]
Yes No
CCFP
Yes 111 (64) 68 (39) <0.001
No 61 (36) 105 (61)
Practice setting
Urban 110 (64) 129 (75) 0.006
Rural 43 (25) 39 (22)
Mixed 19 (11) 5 (3)
Hospital admitting privileges
Yes 89 (52) 72 (42) 0.010
No 83 (48) 101 (58)
Eligible respondents 172 173 —
a Significant association for reporting set at p < 0.01 by chi-square
or unpaired t-test.
CCFP = certificant of the Canadian College of Family Physicians.
TABLE II Characteristics of the 172 physicians responding to the
survey
Characteristic n (%) a
Aware of the Rapid Palliative Radiotherapy Program?
Yes 31 (18)
No 141 (82)
Have referred patients to the RPRP?
Yes 15 (8)
No 157 (92)
Have referred patients for palliative radiotherapy outside
of the RPRP?
Yes 96 (56)
No 76 (44)
Number of cancer patients seen in the past month.
None 6 (4)
1–5 76 (44)
6–10 55 (32)
>10 35 (20)
Frequency of participating in the care of patients with
advanced cancer.
Never 1 (<1)
Rarely 21 (12)
Sometimes 57 (33)
Often 92 (54)
Frequency of providing palliative care.
Never 5 (3)
Rarely 29 (17)
Sometimes 56 (33)
Often 82 (47)
Previous training in palliative care.
Yes 69 (40)
No 103 (60)
Training in radiation oncology.
Yes 17 (10)
No 153 (90)
a The number of physicians who answered each question ranged
from 116 to 172.FITZGIBBON et al.
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radiotherapy in treating painful metastatic bone dis-
ease. Most responders (86%) indicated their willing-
ness to attend education sessions in radiation
oncology. Interestingly, 55% of responders perceived
that the waiting time for patients to receive radio-
therapy was a factor that influenced their decision to
refer patients for radiotherapy, suggesting that im-
proved access to radiation oncology services via the
RPRP should improve referral rates.
TABLE III Factors influencing family physicians to refer patients to palliative radiotherapy
Answer a (%)
No Yes
How much would a family physician’s decision to refer a patient for palliative radiotherapy be influenced by:
difficulty in contacting a radiation oncologist? 63.8 36.2
uncertainty of the referral process? 73.1 26.9
waiting time for assessment by radiation oncologist? 46.7 53.3
waiting time for radiotherapy? 44.5 55.5
uncertainty of the benefit of radiotherapy? 45.8 54.2
uncertainty of the side effects of radiotherapy? 50.3 49.7
distance a patient lived from the Ottawa Regional Cancer Centre? 56.5 43.5
type of cancer? 20.4 79.6
age of the patient? 57.1 42.9
functional status of patient? 33.1 66.9
anticipated inconvenience to the patient? 50.3 49.7
patient’s preference? 21.5 78.5
life expectancy of patient? 56.8 43.2
What would you consider the minimum life expectancy to be, prior to referring a patient for palliative radiotherapy? (%)
<1 month 24.4
1–3 months 35.9
4–6 months 21.8
>6 months 9.0
Unsure 8.9
a “No” includes the responses “not at all” and “a little”; “yes” includes the responses “somewhat” and “a lot.”
FIGURE 1 Perception by family physicians of the effectiveness of
palliative radiotherapy. For each of indications shown, expert
opinion suggests that radiotherapy is “effective” 4,9.
TABLE IV Physician factors related to prior referral of patients for
palliative radiotherapy
Prior
Factor referral a (%)
No Yes
Sex
Male 29 73
Female 71 27
Regularly provides palliative care?
Yes 75 96
No 25 4
Urban practice location?
Yes 75 55
No 25 45
Hospital privileges?
Yes 40 62
No 60 38
Previously sought advice from radiation oncologist?
Yes 29 73
No 71 27
Considers access to radiation oncologists adequate?
Yes 35 60
No 25 32
Never tried 40 8
Considers radiotherapy effective for treating painful
bony metastases?
Yes 92 99
No 8 1
a The number of physicians who provided data on each factor var-
ied from 116 to 172.AWARENESS AND USE OF THE RPRP
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The fact that only 18% of responders were aware
of the RPRP indicates that the interventions originally
used by the cancer centre to inform family physicians
of the establishment of the RPRP were not effective.
As a first step in correcting this lack of awareness,
the survey has identified a subgroup of family physi-
cians who, if they become aware of the program will
be likely to use the RPRP—that is, the 56% of respond-
ers who had previously referred patients for pallia-
tive radiotherapy at the cancer centre (Table IV). These
family physicians are more likely to be regularly car-
ing for patients with cancer, to be providing pallia-
tive care, to have hospital admitting privileges, and
to be practicing outside major urban centres. This
subgroup of responders matches the profile of the
family physician that the RPRP intended to assist; logi-
cally, this group could be used as a target population
for both the design and assessment of interventions
to improve awareness of the RPRP. Family physicians
in this group are widely dispersed throughout East-
ern Ontario and could be regarded as a local resource
in cancer knowledge for other health care providers
in their areas.
Limitations in this study should be acknowledged.
Despite repeated contact attempts, the survey re-
sponse rate was 50%. The survey sampling frame
was a composite of two lists, from which eligible
physicians may have been excluded. Thus, the sur-
vey results may still imprecisely reflect family phy-
TABLE V Factors related to family physician awareness of the Rapid Palliative Radiotherapy Program a
Factor Unaware (%) Aware (%) Independent predictors
(n=141) (n=31) [OR (95% CI)]
Previously sought advice b from radiation oncologist?
Yes 52 81 4.60 (1.78–11.96)
No 48 19
Provides palliative care c for their patients.
Yes 77 94 4.26 (0.96–18.80)
No 23 6
Previous referral of patients for palliative radiotherapy?
Yes 50 81 4.12 (1.59–10.62)
No 50 19
a Multivariate logistic regression model estimating the probability of a family physician being “aware” of the Rapid Palliative Radiotherapy
Program. A significant association (Wald p(z) < 0.25 by chi-square) was necessary for a factor to be eligible for entry into logistic model
building. Final model:
Logit (aware of RPRP) = b0 + b1 + b2
Variable Regression coefficient (b) OR (95% CI) Wald p(z)
0. Intercept –2.982
1. Advice 1.142 3.13 (1.15–8.53) 0.026
2. Palliative care 1.228 3.42 (1.32–8.86) 0.012
b Test for model validity: classification = Hosmer and Lemeshow “goodness of fit” (c2 = 2.924, df =6, p = 0.82).
c Test for model validity: discrimination = area under the ROC curve c = 0.69.
OR = odds ratio (odds of the outcome occurring for every unit increase in an individual independent variable, controlling for the other
variables in the model); CI = confidence interval; intercept = a mathematical constant (no clinical interpretation);  ROC = receiver operator
curve (test for ability of the model to discriminate between variables).
sician awareness and knowledge of the effectiveness
of radiotherapy. Finally, answers to survey questions
may have been influenced by social desirability,
which may affect our estimate of physician awareness.
5. CONCLUSIONS
The results of this survey reveal that, although fam-
ily physicians play a key role in providing ongoing
primary care for patients with advanced cancer, most
are unaware of a program that was developed spe-
cifically to facilitate family physician access to pal-
liative radiotherapy services. By identifying barriers
to the use of the RPRP and suggesting a receptive
pilot group of family physicians, the results of the
survey can guide the development and delivery of a
focused plan to improve knowledge, awareness, and
use of palliative radiotherapy services by family phy-
sicians. This increased awareness and knowledge will
lead ultimately to improved patient care.
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